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Described here the results of the efficacy of varied doses of gamma
globulin used during an epidemic of infectious hepatitis in two
Alaskan fishing villages.
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N RECENT YEARS much attention has
been focused on finding minimal
dose of gamma globulin effective in
preventing clinical infectious hepatitis.
Studies designed to determine the op-
timal dose have been primarily con-
ducted in institutions for the mentally
retarded, an environment in which sus-
ceptible individuals are often exposed
to hepatitis over a period of months or
years in contrast to the usual brief ex-
posure that occurs in community out-
breaks. Reported studies on the effect
of gamma globulin in both urban and
rural community epidemics have been
retrospective in nature and have gen-
erally involved the evaluation of only
one dose of gamma globulin. The study
in this paper was undertaken to com-
pare the relative efficacy of three differ-
ent gamma globulin doses administered
simultaneously during a widespread
community epidemic. The three doses
administered were 0.06 ml/lb, 0.01 ml/
lb, and 0.005 ml/l) of body weight.
In August, 1961, members of the
Communicable Disease Center, Arctic
Health Research Center. and the Alaska
Department of Health and Welfare par-
ticipated in the investigation and con-
trol of an epidemic of infectious hepa-
titis in Alaska, involving two small In-
dian fishing villages, Hoonah and Ex-
cursion Inlet. Gamma globulin was ad-
ministered to 619 individuals compris-
ing 84 per cent of the susceptible popu-
lation in the two villages at the height
of the epidemic.
Genera I
Hoonah is a small fishing village with
a population in the winter of slightly
over 800 persons. It is located on an
island approximately 40 miles west of
Juneau in southeast Alaska. The village
consists almost entirely of Tlingit In-
dians, there being only some 20 non-
native residents. Salmon fishing and
crab canning comprise the basic indus-
tries of Hoonah.
Excursion Inlet is located 20 miles
from Hoonah across a body of water
called Icy Strait. It has a summer
population of approximately 300 resi-
dents. About half of the Excursion Inlet
inhabitants are members of Hoonah
families who work from late June
through September at the large salmon
cannery there, frequently commuting
back and forth between Hoonah and
Excursion Inlet on weekends. When the
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Figure 1-Hoonah-Excursion Inlet Infectious Hepatitis Epidemic, Cases by Week
of Onset, 1961
cannery closes in September they re-
turn to their permanent homes in
Hoonah.
In both villages the Indians live in
crowded quarters consisting of two- to
five-room frame houses generally within
50 feet of one another. All but a few
homes have running water supplied
from isolated reservoirs in each village.
Both the community toilet in Excursion
Inlet and individual flush toilets in
most of the houses in Hoonah empty
through the municipal sewage system
into the bay, near the docks of each
village. A 20-foot tide and 20 inches
of rainfall each year help to prevent
stagnation.
There is no history of a previous
epidemic of hepatitis in either Hoonah
or Excursion Inlet. Questioning of in-
habitants revealed only eight cases of
hepatitis which occurred sporadically 11
to 41 years prior to the epidemic.
Method of Investigation
From August 5 to 16, 1961, a team of
three physicians and a sanitary engi-
neer participated in the investigation
of the epidemic. It was assisted in the
villages by a public health nurse who
regularly spends alternate six-week pe-
riods in Hoonah; under normal cir-
cumstances there are no physicians in
either Hoonah or Excursion Inlet.
During the first four days of the in-
vestigation the team visited all house-
holds with cases of hepatitis. Detailed
case histories were taken and all in-
dividuals with recent illness were exam-
ined.
Gamma globulin was administered to

























Table 1-Hoonah-Excursion Inlet, Alaska,
Infectious Hepatitis Epidemic, 1961
Attack Rate by Age Group
Age Total No. of Attack
Group Population Cases Rate (%)
0-4 132 7 5.3
5-9 120 42 35.0
10-14 108 36 33.3
15-19 85 9 10.6
20-29 99 4 4.0
30-39 82 7 8.5
40-49 68 1 1.5
50+ 120 0
Total 814 106 13.0
all presumed susceptibles who attended
improvised clinics in Hoonah on August
9 and 10, and in Excursion Inlet on
August 11 and 12. Two lots of gamma
globulin supplied by the American Red
Cross* were administered in a random-
ized fashion so that each person was
as likely to receive 0.005 ml, 0.01 ml, or
0.06 ml gamma globulin per pound of
body weight. At the time of adminis-
tration complete household rosters were
obtained including data on inoculated
and uninoculated family members.
Follow-up surveillance was conducted
by repeated visits to the villages by one
or more of the team physicians during
September and October and by the pub-
lic health nurse who remained in the
village for over five months after gamma
globulin administration. Surveillance
was also aided by a group of village
women who regularly canvassed house-
holds for new cases. The list of nonim-
munized individuals was supplemented
by information gathered from a door-
to-door survey during October, 1961.
A person was presumed to have had
hepatitis if during the epidemic he ex-
perienced an acute illness characterized
by one or more of the signs or symp-
* Squibb Laboratories-Lots: 330-2, 331-1.
toms in each of the "specific" and "non-
specific" categories listed below.
"Specific":
(1) history of brownish urine and/or
whitish stools








(4) upper abdominal pain
(5) headache
A person was considered to have had
icteric hepatitis if in addition he gave
a history of jaundice or, upon examina-
tion, he was found to have either gen-
eralized jaundice or scleral icterus.
The Epidemic
The epidemic began in early June,
1961, when a child of a Hoonah family
became ill approximately one month
following a visit to another village. This
index case infected children of several
other families; the illness spread rapidly
through the village. The virus was ap-
parently taken into Excursion Inlet in
late June by one of the first families
infected and quickly spread through the
Tlingit community there.
In all, 106 cases of infectious hepa-
titis occurred between June and Septem-
ber, 1961. The epidemic curve is shown
in Figure 1. The time of gamma
globulin administration is indicated as
is the residence of the cases at the time
of the epidemic. Of special note is the
four-month duration of the epidemic and
the sharp fall-off of cases shortly after
gamma globulin administration.
Table 1 shows the attack rates by age
groups for the epidemic. The over-all
attack rate was 13 per cent. By far
the greatest concentration of cases was
in the 5-14-year-age group. 'Over 30
per cent of the children in these age
groups developed infectious hepatitis.
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Table 2-Hoonah-Excursion Inlet, Alaska, Infectious Hepatitis Epidemic, 1961
Number of Persons and Hepatitis Cases by Age Groups Receiving Each Dose of Gamma Glo6ulin
0.005 ml/lb 0.01 ml/lb 0.06 ml/lb No Gamma
Gamma Globulin Gamma Globulin Gamma Globulin Globulin
Age No. No. No.
Group Received Cases Received Cases Received Cases No. Cases
0-4 41 2 48 2 33 1 9 1
5-9 24 4 21 3 32 3 11 0
10-14 23 1 19 2 26 2 10 1
15-19 20 1 21 1 22 1 16 0
20-29 28 0 32 0 19 1 18 1
30-39 23 0 27 0 15 0 11 1
40-49 13 0 20 0 20 0 15 1
50+ 23 0 29 0 40 0 28 0
Total 195 8 217 8 207 8 118 5
The cases were equally divided between
the sexes.
Person-to-person transmission ap-
peared to be the mode of spread in this
epidemic. Virtually every case gave a
history of contact with previous cases.
The water supplies of each village came
from isolated reservoirs and, in Hoonah,
families using separate water supplies
were also involved. Further, there were
no large events or celebrations prior to
the beginning of the epidemic at which
a common exposure might have oc-
curred. Lastly, the age-specific attack
rates and the four-month duration of the
epidemic are best explained by person-
to-person transmission.
In general, the illness was mild with
no fatalities. Less than 25 individuals,
primarily adults, required hospitaliza-
tion. There were no deaths. Of the
106 cases. 88 (83 per cent) were jaun-
diced; slightly more than 75 per cent
had systemic complaints of fever, chills,
anorexia, nausea, and vomiting.
Betweeni August 9 and 12. at the peak
of the epidemic, 619 individuals (rep-
reseniting 841 per cent of the population
at risk) received gamma globulin. Of
the 619 individuals immunized, 195 re-
ceived a dose of 0.005 ml/lb, 217 re-
ceived 0.01 ml/lb, and 207 received
0.06 ml/lb (Table 2).
Results
Following the administration of gam-
ma globulin, 29 individuals developed
infectious hepatitis. As seen in Table
2, eight cases occurred in each of
the three dosage groups; five occurred
among those not inoculated. The cases
that occurred after gamma globulin ad-
ministration were again most frequently
observed among children 5-14 years of
ag-e. Among the group not receiving
gamma globulin the five postimmuniza-
tion cases were generally older. It must,
however, be noted that this group did
not represent a control. It consisted of
those individuals who did not appear at
the clinics for gamma globulin; many
were al)sent from the village dturing
most or all of the epidemic.
The distribution in time of hepatitis
cases with onset following ,amma glob-
ulin administration is shown in Figure
2. There was a definite clustering of
cases during the first week after gamma
globulin administration among each of
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the immunized groups. Although the
number of cases is too small for firm
conclusions, it is interesting to note that
cases, both icteric and anicteric, oc-
curred with approximately equal fre-
quency among each of the dosage
groups. Attack rates based on cases
occurring more than six days after glob-
ulin administration (Table 3) reveal
little difference between the test groups;
those not given gamma globulin had- a
higher rate.
Discussion
In the initial studies' of gamma glob-
ulin efficacy in the prevention of clin-
ical hepatitis, a dose of 0.15 ml per
pound was used and found to be effec-
tive. The effectiveness of lower dosages,





personnel2 and among children in an
orphanage3 was soon demonstrated.
Later, an even smaller amount of
gamma globulin, 0.01 ml per pound,
was evaluated in a series of studies con-
duc-ed during institutional outbreaks.4-6
This dosage similarly conferred good
protection. Among household contacts
during community outbreaks, Hsia, et
al.,7 in 1954 observed only one case of
hepatitis among 95 exposed individuals
receiving 0.01 ml/lb as compared with
13 cases among 95 uninoculated in-
dividuals. Similarly, Ashley8 in 1954
found that 1.1 per cent of 269 exposed
household contacts receiving 0.01 ml/lb
developed hepatitis, while 16.8 per cent
of 690 uninoculated household contacts
became ill. Others,9"10 have also con-
firmed these findings.
Recent observations by Ward and
U
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l Icteric Case II-Anicteric Case
Figure 2-Onset of Infectious Hepatitis Cases by Two-Day Interval After Administra-




Table 3-Hoonah-Excursion Inlet, Alaska
Infectious Hepatitis Epidemic, 1961
Hepatitis Cases with Onset More Than Six Days
After Administration of Gamma Globulin
Dose of Population Cases
Gamma Globulin at After Six Per
Administered Risk Days cent
0.005 195 2 1.0
0.01 217 4 1.8
0.06 207 4 1.9
Total 619 10 1.6
No gamma
globulin 118 5 4.2
Krugman,11-13 based on studies con-
ducted in an institution where hepatitis
is endemic have questioned the ade-
quacy of the dosage of 0.01 ml/lb.
This dosage in their first trial did not
appear to produce the high degree of pro-
tection for either the inmates or the em-
ployees of the institution as compared
to the protection afforded by 0.06 ml/lb
of body weight in later trials.
The study reported was undertaken
to provide some additional data on the
question of gamma globulin dosage. At
the time of globulin administration the
virus was widespread in the two com-
munities; gamma globulin had not been
administered in the villages. Previous
outbreaks in Alaskan Indian villages14
suggested that the epidemic might well
persist for as long as eight months with
over-all attack rates of 28 per cent or
more. However, following gamma glob-
ulin administration, the epidemic in
Hoonah subsided surprisingly rapidly
and after 38 days no cases were ob-
served over the succeeding six months.
Although 24 cases occurred among
the three study groups, most occurred
during the immediately succeeding
week; only ten occurred after the sixth
day. The equal distribution of cases
both in severity and time suggests there
was no effective difference in protection
based on dosage.
Additional cooperative studies em-
ploying different dosages of gamma
globulin from a single lot are in progress.
Summary
A total of 106 cases of infectious
hepatitis occurred among 814 individ-
uals in Hoonah and Excursion Inlet,
Alaska, from June through September,
1961. At the height of the epidemic
gamma globulin was administered in
random fashion to 619 or 84 per cent of
the population at risk in dosages of
0.005 ml/lb, 0.01 ml/lb, and 0.06 ml/lb
of body weight. Shortly following ad-
ministration of gamma globulin there
was an abrupt fall-off in the number of
cases of clinical hepatitis. Although a
true control group was lacking, the
sharp drop-off in the epidemic curve
following gamma globulin administra-
tion and the clustering of post gamma
globulin cases during the first week
after inoculation suggests that gamma
globulin was effective in terminating the
epidemic. If gamma globulin adminis-
tration was effective in the two Indian
villages, this study would indicate that
there was no significant difference in
this epidemic in the relative efficacy
of 0.005 ml/lb, 0.01 ml/lb, and 0.06
ml/lb of body weight.
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Memorial Fund Honors Alfred L. Burgdorf
A memorial fund is being established in honor of Dr. Burgdorf, for 22 years
health director of the Hartford (Conn.) Health Department, who died in 1962. It
is proposed that the memorial include the renaming of the Hartford Health Depart-
ment to the Dr. Alfred L. Burgdorf Health Center, an annual lecture in public
health and preventive medicine, and the creation of a permanent public health
library fund. Those wishing to contribute should make checks payable to the Alfred
L. Burgdorf, M.D., Memorial Fund, to be forwarded to the Hartford National Bank
and Trust Company.
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